Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Deferred Taxes (2021 - 2025)

Strata Critical Medical (SRTA) has disclosed Deferred Taxes for 5 consecutive years, with -$126000.0 as the latest value for Q4 2025.

  • Quarterly Deferred Taxes fell 20.0% to -$126000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $432000.0 through Dec 2025, up 269.41% year-over-year, with the annual reading at $432000.0 for FY2025, 269.41% up from the prior year.
  • Deferred Taxes for Q4 2025 was -$126000.0 at Strata Critical Medical, down from $554000.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $554000.0 in Q3 2025, with the low at -$3.6 million in Q3 2021.
  • Average Deferred Taxes over 5 years is -$387533.3, with a median of -$109000.0 recorded in 2021.
  • The sharpest move saw Deferred Taxes tumbled 608.26% in 2022, then surged 569.49% in 2025.
  • Over 5 years, Deferred Taxes stood at -$109000.0 in 2021, then crashed by 608.26% to -$772000.0 in 2022, then plummeted by 32.51% to -$1.0 million in 2023, then surged by 89.74% to -$105000.0 in 2024, then dropped by 20.0% to -$126000.0 in 2025.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$126000.0, $554000.0, and $21000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.